The Clotalyst Autologous Activation System rapidly produces up to 10 ml of autologous clotting factors from 12 ml of the patient’s blood at the point-of-care. When combined with the leukocyte-rich platelet–rich plasma (L-PRP) produced by the GPS III Platelet Concentration System, the autologous clotting factors from the Clotalyst Autologous Activation System activate platelets and initiate fibrin formation and cross-linking to form a platelet gel in under 15 seconds.
Zimmer Biomet Biologics has re-designed the Clotalyst® Autologous Serum System to the new and improved Clotalyst® Autologous Activation System. The key features of the new design include:
Autologous Activation Solution
- No pooled or bovine sources
- Eliminates risk of bovine spongiform encephalopathy (BSE)
- Eliminates potential source related coagulopathies
User-Friendly
- Minimal steps required for processing
- No heating step required
- No centrifugation step required
Reliable
- Consistently produces up to 10 ml of activation solution
- Clots platelet-rich plasma in less than 15 seconds
- Activation solution stable up to four hours after preparation
Convenient Design
- Single use disposable device
- No additional mechanical processing required
- Total processing time of less than 20 minutes
